Exploring Best Practices for Diagnosis and Management of Adult-Onset Stills Disease

Access Activity

Overview / Abstract:

Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease. Case studies are utilized to share the faculty’s experience in diagnosis and treatment, so as to facilitate integration into clinical practice.


Jun 30, 2022


Nurse Practitioner , Nursing CNE, Physician CME


Webinar / Webcast / Video

Credits / Hours

1.25 AMA PRA Category 1 Credit(s)TM, 1.25 ANCC Contact Hours



Presenters / Authors / Faculty

Petros Efthimiou, MD, FACR
New York Rheumatology Care, PC
New York, New York
Clinical Professor of Medicine
Ross University School of Medicine
Miramar, Florida

Olga Petryna, MD, FACR
Clinical Assistant Professor
Division of Rheumatology
NYU Grossman School of Medicine
New York, New York

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Novartis Pharmaceutical Corporation.

Keywords / Search Terms

Annenberg Center for Health Sciences at Eisenhower polygenic autoinflammatory syndrome canakinumab AOSD Still’s Disease Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map